相关实验视频

Updated: May 8, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

伊内比利祖马布在一般化严重肌痛性肌痛症的第三阶段试验

Richard J Nowak¹, Michael Benatar², Emma Ciafaloni³

¹Yale University, New Haven, CT.

The New England journal of medicine

|April 9, 2025

概括

伊涅比利祖马布治疗显著改善了一般化骨髓灰质炎患者的日常功能,并减少了疾病严重程度. 这种B细胞消耗疗法在3期试验中显示出有效性.

科学领域:

免疫学免疫学免疫学
神经学神经学
临床试验临床试验

背景情况:

自身免疫性全般性肌痛性肌痛症 (gMG) 的特征是肌肉疲弱的波动.
伊内比利祖马布向CD19+B细胞,这些细胞是gMG病原发生的关键参与者.

研究的目的:

评估伊内比利祖马布在gMG患者中的疗效和安全性.
评估伊涅比利祖马布对疾病活动和日常功能的影响.

主要方法:

第三阶段,双盲,随机,安慰剂对照试验.
参与者接受了伊内比利祖马布或安慰剂,并逐渐减少葡萄糖皮质激素治疗.
主要终点:在26周内,肌痛严重症日常生活活动 (MG-ADL) 评分的变化.

主要成果:

与安慰剂相比,伊内比利祖马布显示MG-ADL得分显著降低 (-4.2vs-2.2).
在量化肌痛严重症 (QMG) 评分中也观察到显著的改善 (-4.8比 -2.3).
常见的不良事件包括头痛和输液相关反应;没有注意到严重不良事件的增加.

结论:

伊内比利苏马布有效地改善了gMG患者的功能,并减少了疾病的严重程度.
这项研究支持伊内比利祖马布作为治疗乙胆受体抗体阳性或肌肉特异性激酶抗体阳性gMG的治疗选择.

更多相关视频

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Vascular Occlusion Training for Inclusion Body Myositis: A Novel Therapeutic Approach

Published on: June 5, 2010

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Preclinical Drug Testing in Scalable 3D Engineered Muscle Tissues

Published on: April 7, 2023

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...